Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers
Clinical trial NCT03144856 · UNKNOWN
Trial details
- NCT number
- NCT03144856
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-22
- Primary completion
- 2019-03-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.